Bioventix (FRA:51B) Valuation Rank

View and export this data going back to 2017. Start your Free Trial

What is Bioventix Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bioventix Valuation Rank Related Terms

Thank you for viewing the detailed overview of Bioventix's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioventix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (FRA:51B) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

BVXP:UK 51B:Germany

Address

27–28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.bioventix.com

Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.